Blog – Orocidin

Ikke-kategoriseret

10 jan 2024

NORDICUS PARTNERS CORPORATION ENTERS INTO A CONSULTANCY AGREEMENT WITH OROCIDIN A/S IN DENMARK

Ikke-kategoriseret

15 maj 2024

NORDICUS PARTNERS CORPORATION ACQUIRES 95% STAKE IN OROCIDIN A/S

Ikke-kategoriseret

11 jun 2024

OROCIDIN – NEW INSIGHTS INTO THE TREATMENT OF PERIODONTITIS

Ikke-kategoriseret

12 nov 2024

NORDICUS PARTNERS CORPORATION ACQUIRES THE REMAINING 5% SHARES IN OROCIDIN A/S

Ikke-kategoriseret

28 jan 2025

OROCIDIN LAUNCHES GROUNDBREAKING DENTAL GEL FOR LONG-TERM PERIODONTITIS TREATMENT

Ikke-kategoriseret

18 feb 2025

OROCIDIN QR-01 SHOWS A GOOD SAFETY PROFILE IN PRECLINICAL TOXICITY STUDY

Ikke-kategoriseret

20 feb 2025

OROCIDIN AND SYNGENE PARTNER TO ACCELERATE BIOTECH INNOVATION

Ikke-kategoriseret

2 apr 2025

OROCIDIN’S QR-01 SHOWS POSITIVE RESULTS IN TREATING PERIODONTITIS IN DOGS

Ikke-kategoriseret

16 okt 2025

NORDICUS PARTNERS CORPORATION ANNOUNCES KEY MILESTONE IN DEVELOPMENT OF OROCIDIN’S BREAKTHROUGH TREATMENT FOR PERIODONTITIS